In this context, it is noteworthy that KRAS‐mutated colon carcinoma cells express high levels of BCAM and efficiently form hepatic metastases in mice, which is inhibited by BCAM‐mimetic peptides blocking LAMA5–BCAM interaction.6 The gene discussed is KRAS; the disease is colon carcinoma.